Torsades de pointes associated with drugs and toxins: Recognition and management

American Heart Journal

Volumn 113, Issue 6, 1987, Pages 1470-1482

  Stratmann, Henry G ^a,b   Kennedy, Harold L ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b SAINT LOUIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ANTIARRHYTHMIC AGENT; ANTIDEPRESSANT AGENT; ARSENIC; ATROPINE; BRETYLIUM; CALCIUM ANTAGONIST; CHLORAL HYDRATE; CHLOROQUINE; CORTICOSTEROID; DIURETIC AGENT; DRUG; GLUCONATE CALCIUM; INSECTICIDE; ISOPRENALINE; LIDOCAINE; MAGNESIUM SULFATE; MEXILETINE; NEUROLEPTIC AGENT; PHENYTOIN; PROPRANOLOL; PSYCHOTROPIC AGENT; SUXAMETHONIUM; TOXIN; VASODILATOR AGENT; VASOPRESSIN; VERAPAMIL;

ADVERSE DRUG REACTION; CARDIOTOXICITY; HEART; HEART VENTRICLE TACHYCARDIA; HUMAN; INTOXICATION; MANAGEMENT; PRIORITY JOURNAL; PROTEIN DIET; QT INTERVAL; REVIEW; TACHYCARDIA; THERAPY; TORSADE DES POINTES;

ANTI-ARRHYTHMIA AGENTS; ELECTROCARDIOGRAPHY; HUMAN; PSYCHOTROPIC DRUGS; TACHYCARDIA; TOXINS; VASODILATOR AGENTS;

EID: 0023244061     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/0002-8703(87)90664-8     Document Type: Article

References (137)

1. La tachycardie ventriculaire a deux foyers opposes variables
2. “Les torsades de pointes”: an unusual ventricular arrhythmia
3. Etiology, warning signs and therapy of torsade de pointes. A study of 10 patients
4. Torsades de pointes: definition and management
5. Torsade de pointes: definitions, causative factors, and therapy: experience with sixteen patients
6. Torsade de pointes the long-short initiating sequence and other clinical features observations in 32 patients
7. Polymorphous ventricular tachycardia associated with normal and long Q-T intervals
8. Tachycardie ventriculaire en torsades de pointe
9. Transient recurrent ventricular fibrillation due to hypopotassemia with special note on the u wave
10. Les torsades de pointe. A propos de 54 cas
11. Tachycardie ventriculaire a foyer variable et dyskaliemie
12. Hypomagnesemic torsades de pointes
13. Paroxysmal ventricular fibrillation in two patients with hypomagnesemia
14. Torsade de pointes and magnesium deficiency
15. Hypocalcemia and intractable ventricular fibrillation
16. Management of recurrent ventricular tachyarrhythmias associated with Q-T prolongation
17. Torsades de pointes: electrophysiologic studies in patients without transient pharmacologic or metabolic abnormalities
18. Detailed analysis of 24 hour ambulatory electrocardiographic recordings during ventricular fibrillation or torsade de pointes
19. Delayed repolarization syndrome
20. Syndrome de QT long avec torsades de pointe, syncopes et insuffisance coronarienne
21. Torsade de pointes complicating acute myocardial infarction
22. Polymorphous ventricular tachcardia in acute myocardial infarction
23. Torsades de pointes: occurrence in myocardial ischaemia as a separate entity. Multiform ventricular tachycardia or not?
24. The long QT syndrome
25. Congenital deaf-mutism, functional heart disease with prolongation of the QT interval, and sudden death
26. A new familial cardiac syndrome in children
27. Torsade de pointes and mitral valve prolapse
28. Q-T prolongation and torsades de pointes in a patient with subarachnoid hemorrhage
29. Cardiac arrhythmias in acute central nervous system disease
30. Cardiac arrhythmia induced by pneumoencephalography
31. Torsade de pointes: manifestation of acute rheumatic carditis
32. Long QT interval and ventricular tachycardia of “torsade de pointe” type in hypothyroidism
33. Repetitive ventricular arrhythmia resulting from artificial internal pacemaker
34. Torsades de pointes: a rare complication of temporary pacing for permanent ventricular pacemaker failure
35. Torsade de pointes, an atypical ventricular tachycardia
36. Torsade de pointes ventricular tachycardia in a newborn infant
37. Varicella myocarditis presenting with unusual ventricular arrhythmias
38. Familial inducible torsade de pointes with normal QT interval
39. Atypical ventricular tachycardia (torsade de pointes). A postoperative enigma
40. “Torsade de pointe”: a distinct entity of ventricular arrhythmia?
41. Ventricular fibrillo-flutter (“torsade de pointe”): an established electrocardiographic and clinical entity
42. Torsade de pointes: polymorphous ventricular tachycardia
43. Tachycardies ventriculaires et torsades de pointes. Frontieres morphologiques entre les dysrythmies ventruculaires
44. Torsades de pointes versus polymorphous ventricular tachycardia
45. Iatrogenic “torsades de pointes” ventricular tachycardia
46. Torsade de pointes: an addition to the nosography of ventricular tachycardia
47. “Torsade de pointes” tachycardia. Re-entry or focal activity?
48. Overdrive pacing in quindine syncope and other long QT-interval syndromes
49. Polymorphous ventricular tachycardia clinical features and treatment
50. Torsade de pointes electrophysiology atypical ventricular tachycardia [Abstract]
51. A mechanism of torsades de pointes in a canine model
52. “Torsade de pointes” initiated by electrical ventricular stimulation
53. U waves and ventricular arrhythmias produced by delayed recovery [Abstract]
54. Value and limitations of programmed electrical stimulation of the heart in the study and treatment of tachycardias
55. Electrophysiologic testing in patients with the long QT syndrome
56. Delayed repolarization (QT or QTU prolongation) and malignant ventricular arrhythmias
57. Bradycardia-dependent triggered activity: relevance to drug-induced multiform ventricular tachycardia
58. Afterdepolarizations as a mechanism for the long QT syndrome electrophysiologic studies of a case
59. Ventricular tachyarrhythmias in the long QT syndromes
60. A classification of antiarrhythmic actions reassessed after a decade of new drugs
61. Quinidine syncope and the delayed repolarizations syndromes
62. Quinidine-induced syncope
63. Intoxication with quinidine
64. Quinidine syncope: torsade de pointes with low quinidine plasma concentrations
65. Quinidine-induced recurrent ventricular fibrillation: (quinidine syncope) treated with transvenous pacemaker
66. Successful treatment by overdrive pacing of recurrent quinidine syncope due to ventricular tachycardia
67. Paroxysmal ventricular tachycardia and fibrillation due to quinidine
68. Adverse reactions to quinidine in hospitalized patients: findings based on data from the Boston Collaborative Drug Surveillance Program
69. Quinidine-induced ventricular flutter and fibrillation without digitalis therapy
70. Torsade de pointes due to quinidine: observations in 31 patients
71. Quinidine syncope. Paroxysmal ventricular fibrillation occurring during treatment of chronic atrial arrhythmias
72. Recurrent ventricular fibrillation precipitated by quinidine. Report of a patient with recovery after 28 paroxysms
73. Procainamide-induced ventricular tachycardia
74. N-acetyl procainamide causing torsades de pointes
75. Polymorphic ventricular tachycardia and ventricular fibrillation due to N-acetyl procainamide
76. Torsade de pointes associated with elevated N-acetylprocainamide levels
77. Torsades de pointes due to N-acetylprocainamide
78. Disopyramide-induced torsade de pointes
79. Disopyramide-induced QT prolongation and ventricular tachyarrhythmias
80. Torsades de pointes, a common arrhythmia, induced by medication
81. Torsade de pointes caused by disopyramide and hypokalemia
82. Torsade de pointes ventricular tachycardia. A complication of disopyramide shared with quinidine
83. Torsade de pointes [Letter]
84. Ventricular tachycardia with torsade de pointes morphology induced by oral disopyramide
85. Ventricular tachyarrhythmias induced by disopyramide and other similar anti-arrhythmic drugs
86. Les torsades de pointe. A propos de 30 observations
87. Torsades de pointes as a manifestation of mexiletine toxicity
88. Mexiletine for treatment of torsade de pointes
89. Aprindine-induced polymorphous ventricular tachycardia
90. Malignant ventricular tachyarrhythmias associated with the use of encainide
91. Polymorphous ventricular tachycardia: clinical characterization, therapy, and the QT interval
92. Amiodarone-induced polymorphous ventricular tachycardia
93. Torsione di punta e amiodarone
94. Acta Med Scand (Suppl)
95. Sotalol-induced torsade de pointes
96. Sotalol, hypokalemia, syncope, and torsade de pointes
97. Syncope par torsade de pointe au cours d'un traitement la chloroquine etude de l'electrogramme hisien et traitement par le verapamil
98. Torsades de pointes and nifedipine [Letter]
99. A case of prenylamine toxicity showing the torsade de pointes phenomenon in sinus rhythm?
100. Prenylamine-induced ventricular arrhythmias and syncopal attacks with Q-T prolongation
101. Syncopes par torsades de pointes induites ou favorisees par la prenylamine
102. Contributo casistico alla conoscenza della tachicardie ventricolare a torsione di punta
103. Ventricular arrhythmias caused by prenylamine
104. Q-T lungo, sincope e prenilamina
105. Prenylamine-induced ventricular tachycardia and syncope controlled by ventricular pacing
106. “Torsades de pointe” induites ou favorisees par la prenylamine
107. Rezidivierende atypische ventrikulare tachykardie “torsade de pointes” nach gabe von lidoflazin
108. Torsades de pointe. Responsabilitie eventuelle d'un vasodilatateur peripherique: le fenoxedil
109. Bepridil et torsades de pointes
110. Les torsades de pointe sous bepridil
111. Electrocardiographic changes and cardiac arrhythmias in patients receiving psychotropic drugs
112. Thioridazine-induced torsade de pointes. Successful therapy with isoproterenol
113. Thioridazine (Mellaril)-induced ventricular tachycardia controlled with an artificial pacemaker
114. Doxepin induced torsade de pointes
115. Q-T prolongation and torsades de pointes ventricular tachycardia produced by the tetracyclic antidepressant agent maprotiline
116. Torsades de pointe apres injection de suxamethonium chez deux coronariens digitalises [Letter]
117. Torsade de pointe. Malignant cardiac arrhythmia induced by amantadine poisoning
118. Torsade de pointes: an unusual manifestation of chloral hydrate poisoning
119. Ventricular arrhythmia induced by vasopressin: torsade de pointes related to vasopressin-induced bradycardia
120. Torsade de pointe favorisees par l'atropine
121. Arsenic-induced atypical ventricular tachycardia
122. Ventricular fibrillation caused by arsenic poisoning
123. Polymorphic ventricular tachycardia and other complex arrhythmias in organophosphate insecticide poisoning
124. Q-T prolongation and polymorphous (“torsade de pointes”) ventricular arrhythmias associated with organophosphorus insecticide poisoning
125. Arrhythmias in organophosphate poisonings
126. Sudden, unexpected death in avid dieters using the liquid-protein-modified-fast diet
127. Prolonged QT interval-ventricular tachycardia syndrome from massive rapid weight loss utilizing the liquid-protein-modified-fast diet: sudden death with sinus node ganglionitis and neuritis
128. Liquid protein diets and torsade de pointes
129. Incidence and clinical features of the quinidine-associated long QT syndrome: implications for patient care
130. Atypical torsade de pointes
131. Syndrom der verlangerten QT-zeit und kammertachykardie “en torsade de pointe” nach behandlung mit prenylamin (Segontin)
132. Un cas de torsade de pointe sous bepridil
133. Torsades de pointes
134. Syncopes par torsades de pointes d'origine iatrogene. Importance d'un terrain predisposant. A propos de 7 observations
135. Atypical ventricular tachycardia (torsade de pointes) induced by amiodarone
136. Quinidine-induced paroxysmal ventricular fibrillation treated with propranolol
137. Magnesium therapy for torsades de pointes